NASDAQ · AVX

Avax One Technology Ltd.. Common

$3.46 -$0.10 (-2.81%) 1D Market open

Key Metrics

$26.59M
Market cap
P/E · TTM
$4.51M
Revenue · TTM
−$79.44M
Net income
EPS · TTM $-123,547.05
Dividend yield
Free cash flow
Beta · 1Y 2.34
EBITDA · TTM −$74.92M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 21
    From its Mar 16 high, the share price fell 65%.

    Peak close $9.99 on Mar 16; trough close $3.45 on Jul 21. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -65%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 1
    The stock moved +22.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 1
  • Feb 25
    The stock moved +16.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 25

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$26.59M
Enterprise value
Shares outstanding7.5M
52-wk range$1.12 – $27.12
Avg volume · 20D84.5K
Net cash
Book value / share$222,062.21
IndustryFinance Services
ExchangeNASDAQ
About Avax One Technology Ltd.. Common
IPO dateJul 8, 2021
Employees7

AVAX One Technology Ltd is a digital infrastructure company focused on digital asset and computing infrastructure.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S5.90
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating -1,679.3%
Net -1,762.5%
FCF
ROE / ROIC -55.6% · —

Financial Health

Current ratio
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital

Cash Flow · TTM

Operating CF −$13.62M
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

1 / 9
Weak fundamentals · 1 of 9 signals passing

Altman Z-Score

-1.7
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings